R&D tax relief, prepared to withstand HMRC scrutiny
We prepare claims under the merged R&D scheme and ERIS, and we defend them if HMRC asks questions. R&D tax relief is all we do.
Every claim we prepare is built to be read closely.
The technical narrative, the qualifying cost schedules and the return entries, prepared by a regulated chartered practice and signed off by a chartered adviser.
-
Merged scheme
15%
What the merged scheme’s 20% expenditure credit is worth per £1 of qualifying spend, net of corporation tax at 25%. It is 16.2% at the 19% rate or where the company is loss-making, and as low as 14.7% where marginal relief applies.
-
ERIS
26.97%
What a loss-making, R&D-intensive SME receives in cash per £1 of qualifying spend under ERIS. The payable credit is not taxable.
-
Intensity test
30%
The R&D intensity a loss-making SME must reach to claim ERIS, measured against total relevant expenditure, not the R&D alone.
Which scheme applies, and what it is worth
Two schemes are in force for accounting periods beginning on or after 1 April 2024. Which one applies depends on the company, not the date: ERIS for a loss-making SME whose relevant R&D expenditure is at least 30% of its total relevant expenditure, and the merged scheme for every other company.
| The merged scheme Companies of every size | ERIS Loss-making, R&D-intensive SMEs | |
|---|---|---|
| Rate | 20% taxable credit on qualifying expenditure | 86% additional deduction and 14.5% payable credit |
| Worth per £1 | 15p net1 at the 25% corporation tax main rate; 16.2p at 19%, or for a loss-maker taking it in cash | Up to 26.97p, tax free1 |
| Who qualifies | Any company with qualifying R&D expenditure | A loss-making SME whose relevant R&D expenditure is at least 30% of its total relevant expenditure2 |
Table notes
- Payable credits are capped at £20,000 plus 300% of relevant PAYE and NIC.
- The 30% denominator is broadly the trading costs in the accounts for the period, not just the R&D ones.
Correct as at 4 September 2026. Every rate since 2015: R&D tax relief rates by year.
Why companies trust us with their claims
Because we are accountable in ways many R&D agents are not. The mis-selling era left companies facing enquiries their advisers would not defend. Our answer is a regulated, chartered practice — and has been since 2017, under every version of the rules since.
Chartered on both fronts
A member firm of both the Chartered Institute of Taxation (CIOT) and ICAEW, led by a dual-qualified founder, with every claim signed off by a chartered adviser.
Regulated by ICAEW
Including anti-money-laundering supervision, with a published complaints route.
Bound by PCRT
Professional Conduct in Relation to Taxation governs every position we take.
Registered with HMRC
Registered with HMRC as a tax adviser, and named on every claim we prepare.
Enquiry support included
In every engagement as standard. If HMRC opens a compliance check, we handle the response.
We stand behind our work
We prepare the right claim, defensibly. Read about our regulation and standards.
Who we work with
Companies whose business is their R&D. Sector by sector, claims trip up in different places — each card names the complication we solve most often.
Life sciences
Grant stacks, CRO contracts and long pre-revenue phases.
→Biotech
Meeting the 30% intensity test while still pre-revenue.
→Medtech
Where regulatory and clinical work crosses the R&D boundary.
→Agritech
Field trials that seasons, sites and weather complicate.
→AI and robotics
Proving an advance in the field, not just a clever product.
→Space
Long programmes, grant funding and hardware that flies once.
→Aerospace and defence
Contracted programmes and who owns the claim.
→Cleantech and energy
Pilot plant, demonstrators and the consumables boundary.
→Software
Drawing the honest line on where software development qualifies.
→Engineering
Separating qualifying development from routine work.
→Manufacturing
Process trials on live production lines, costed defensibly.
→All sectors
Every sector we work in, including those not shown here.
→How it works
Four steps, one chartered adviser throughout. Your fee is agreed in writing before work starts, with no hidden costs.
See the full process-
Scoping call
A conversation about your work and your numbers. If we do not think you qualify, we say so.
-
Technical and financial workstreams
We interview your competent professionals, set the project boundaries and build the qualifying cost schedules.
-
Report and return
The technical report, the Additional Information Form and the return entries, prepared and filed by us as HMRC-registered agents.
-
Submission and aftercare
We submit, track progress with HMRC, and enquiry support is included as standard.
- Contingent fee, agreed before work starts
- Signed off by a chartered adviser
- Enquiry support included as standard
Our clients’ words
Hear from the R&D-performing companies we act for. More client feedback is on our testimonials page.
Recognition
Finalist, One Nucleus Awards 2026: Most Innovative Professional Services Company
Finalist, Finance Awards Wales 2026: Independent Practice of the Year
Business Wales Accelerated Growth Programme Gold Partner
Memberships and associations
We are members of, and work alongside, the innovation and life-sciences networks our clients operate in, across the UK.
Latest thinking
Technical analysis and firm news from the team, written by the advisers who prepare the claims.

Talk it through with a chartered adviser
A first conversation costs nothing and commits you to nothing. You will speak to a qualified adviser, not a salesperson.
- Call
- 0330 223 4 223
- hello@limestonegrey.com
- Based
- Cardiff, serving the UK











